Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

RCUS holding history

Arcus Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCUS overviewAll 13F holders of RCUSFull Q2 2026 holdings

Shares (Q2 2026)
96,417
Value
$2.97M
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of RCUS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202696,417$2.97M<0.1%−162,983−62.8%ReducedHolders
Q1 2026259,400$5.60M<0.1%+173,830+203.1%AddedHolders
Q4 202585,570$2.04M<0.1%+65,699+330.6%AddedHolders
Q3 202519,871$270.2K<0.1%−31,453−61.3%ReducedHolders
Q2 202551,324$417.8K<0.1%−4,717−8.4%ReducedHolders
Q1 202556,041$439.9K<0.1%+56,041NewHolders
Q4 20240$00.0%−13,501−100.0%Sold outHolders
Q3 202413,501$206.4K<0.1%−17,264−56.1%ReducedHolders
Q2 202430,765$468.6K<0.1%−36,777−54.5%ReducedHolders
Q1 202467,542$1.28M<0.1%+67,542NewHolders
Q3 20230$00.0%−9,995−100.0%Sold outHolders
Q2 20239,995$203.0K<0.1%+9,995NewHolders
Q1 20230$00.0%−26,804−100.0%Sold outHolders
Q4 202226,804$554.3K<0.1%+26,804NewHolders
Q2 20220$00.0%−44,087−100.0%Sold outHolders
Q1 202244,087$1.39M<0.1%−288,907−86.8%ReducedHolders
Q4 2021332,994$13.5M<0.1%+140,031+72.6%AddedHolders
Q3 2021192,963$6.73M<0.1%−161,983−45.6%ReducedHolders
Q2 2021354,946$9.75M<0.1%−204,363−36.5%ReducedHolders
Q1 2021559,309$15.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.